Sen Tom Harkin (D, Iowa) said Congress must overcome President Bush's July veto of HR 810, the Stem Cell Research Enhancement Act, which would make available multiple stem cell lines permissible for use in federally funded medical research.
Harkin's comments came during a September 6 Senate Appropriations Subcommittee on Labor, Health and Human Services and Education hearing on controversies surrounding stem cell research. At center stage was testimony surrounding Advanced Cell Technology (ACT) Inc of Worcester, Mass, and its findings published online ahead of print in Nature (Klimanskaya I et al. Nature. August 23, 2006. doi: 10.1038/nature05142) describing a technique for developing stem cell lines from individual blastomeres without destroying the embryo.
Mitka M. Stem Cell Research. JAMA. 2006;296(14):1720. doi:10.1001/jama.296.14.1720-b
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: